|
HS Code |
350140 |
| Chemical Name | 3,6-Dihydroxypyridazine |
| Molecular Formula | C4H4N2O2 |
| Molecular Weight | 112.09 g/mol |
| Cas Number | 50567-11-6 |
| Appearance | White to off-white solid |
| Melting Point | Over 300°C (decomposes) |
| Solubility In Water | Slightly soluble |
| Structure | Pyridazine ring with hydroxyl groups at positions 3 and 6 |
| Smiles | C1=CC(=NN=C1O)O |
| Inchi | InChI=1S/C4H4N2O2/c7-3-1-2-4(8)6-5-3/h1-2,7-8H |
| Synonyms | 3,6-Pyridazinediol |
As an accredited 3,6-Dihydroxypyridazine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 3,6-Dihydroxypyridazine is supplied in a sealed amber glass bottle containing 25 grams, labeled with hazard and handling information. |
| Shipping | Shipping for **3,6-Dihydroxypyridazine** involves carefully packaging the chemical in tightly sealed, labeled containers to prevent moisture and contamination. The shipment complies with international transport regulations for chemical substances, typically as non-hazardous. Proper documentation and safety data sheets accompany each shipment to ensure safe and efficient delivery. |
| Storage | 3,6-Dihydroxypyridazine should be stored in a tightly closed container, in a cool, dry, and well-ventilated area, away from direct sunlight and incompatible materials such as strong oxidizing agents. It should be kept at room temperature and protected from moisture. Properly label the storage container and ensure access is limited to trained personnel to maintain safety and chemical integrity. |
|
Purity 99%: 3,6-Dihydroxypyridazine with a purity of 99% is used in pharmaceutical intermediate synthesis, where it ensures high-yield and low-impurity final products. Melting Point 255°C: 3,6-Dihydroxypyridazine with a melting point of 255°C is applied in high-temperature organic reactions, where it maintains chemical integrity and reaction consistency. Particle Size <10 μm: 3,6-Dihydroxypyridazine with particle size less than 10 μm is utilized in catalyst formulation, where it enhances reactivity and uniform dispersion. Aqueous Solubility 50 mg/mL: 3,6-Dihydroxypyridazine with an aqueous solubility of 50 mg/mL is used in biotechnological assays, where it improves solution homogeneity and assay accuracy. Stability Temperature up to 120°C: 3,6-Dihydroxypyridazine with stability up to 120°C is employed in polymer modification processes, where it retains chemical activity during processing. UV Absorbance λmax 315 nm: 3,6-Dihydroxypyridazine featuring UV absorbance at λmax 315 nm is applied in analytical reference standards, where it provides reliable quantification in UV spectrophotometry. Moisture Content <0.5%: 3,6-Dihydroxypyridazine with moisture content below 0.5% is used in specialty coating formulations, where it prevents unwanted hydrolysis and enhances shelf life. Analytical Grade: 3,6-Dihydroxypyridazine of analytical grade is applied in chemical research laboratories, where it guarantees reproducible experimental results. Molecular Weight 126.09 g/mol: 3,6-Dihydroxypyridazine with a molecular weight of 126.09 g/mol is used in computational drug design, where its precise mass facilitates accurate molecular modeling. Residual Solvent <10 ppm: 3,6-Dihydroxypyridazine with residual solvent content less than 10 ppm is used in fine chemical manufacturing, where it assures compliance with regulatory purity standards. |
Competitive 3,6-Dihydroxypyridazine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every once in a while, a chemical compound stands out not only for its unique structure but also for what it brings to the research table. 3,6-Dihydroxypyridazine is one of those chemicals. As someone with a knack for working in laboratory environments and tracking chemical development over the years, I keep returning to certain core questions: What does a compound actually do for the people who work with it? How does it solve real problems in the lab, and in what ways does it outshine similar substances?
3,6-Dihydroxypyridazine, as the name suggests, features hydroxyl groups at the 3 and 6 positions on a pyridazine ring. This minor tweak in its chemical backbone changes its reactivity, solubility, and how it interacts with other molecules. It catches the eye in pharmaceutical research settings, fine chemical synthesis, and even in early pharmaceutical discovery stages. Its purity is usually rated at or above 98 percent, often delivered as a fine white to pale off-white powder, and most common research volumes fall between 1 gram and 500 grams. That’s a decent batch for ongoing studies or custom synthesis projects.
In my own experience, the handling and storage conditions of such pyridazine derivatives are pretty straightforward compared to more volatile or sensitive analogues. As long as it stays dry and sealed, there’s little drama—researchers can focus on what matters most: the science. The melting point sits comfortably in the usual lab-processing range (around 280 degrees Celsius, by most published data), making it easier to incorporate into thermal reactions or further structural modifications. Water solubility can be limited due to the pyridazine core, but the hydroxyl groups offer more polarity than usual, which sometimes enables forms of reactivity that are out of reach with less functionalized ring structures.
Roll up the sleeves, and it’s all about reactivity. The hydroxy groups at those specific positions provide unique handles for bond formation, often opening routes to nitrogen- and oxygen-rich heterocyclic structures. Medicinal chemists hunting for building blocks to test as enzyme inhibitors or receptor binders usually look for molecules like this. One of my colleagues specialized in using hydroxylated pyridazine rings as central scaffolds in their anti-inflammatory drug development. They noticed that the dual-positioned hydroxy groups helped with hydrogen bonding patterns in finished drug candidates—something less probable in more symmetrical benzenes or pyridines without targeted functionality.
Beyond the lab bench, journals have reported how this compound gives rise to bifunctional intermediate compounds—elusive building blocks not easily available elsewhere. Its chemical nature opens the doors to a range of nucleophilic substitutions and cyclizations. Even for teams more interested in material science or polymer development, having two hydroxy groups instead of one means new branches for polymerization or cross-linking, sometimes playing unexpected roles in creating novel materials.
Some might point out that there are plenty of pyridazine derivatives on the market already, including 3-hydroxypyridazine or 6-hydroxypyridazine as single-substituted options, and broader nitrogen-containing aromatic rings like pyrazines or pyrimidines. Each compound sinks or swims depending on its accessibility, price, and what unique chemistry it enables. I’ve seen labs opt for the mono-hydroxy variants when they want more selective reactions, but for projects looking for rigidity and new exit vectors, the dihydroxy variant often gets picked up.
Many researchers talk about hopscotching between isomers to beat issues with solubility or compatibility in catalytic cycles. Some N-oxide or methyl-protected derivatives offer better solubility in organic solvents, but they often come with more synthetic steps or unstable intermediates. A big draw for 3,6-Dihydroxypyridazine is often its ability to act both as a hydrogen donor and acceptor, which opens up secondary interactions during complex formation or hydrogen bonding studies.
I remember one project focused on copper-catalyzed cross-coupling. The ligand field provided by two hydroxyl groups stabilized the transition state in ways single-hydroxy analogues never quite nailed, yielding higher purities and fewer byproducts. Sometimes, that is the difference between a result fit only for a notebook and one ready for publication.
Chemists know better than to trust every new compound. Safety and handling come up in shop meetings much more than the sales representatives would ever admit. With 3,6-Dihydroxypyridazine, most published material and firsthand accounts suggest a pretty low-risk profile. There’s no immediate risk of volatilization, and it doesn’t tend to set off allergic reactions unless someone mishandles dust or residues—normal lab hygiene is usually more than enough. Chemical suppliers share that it ships safely under standard ambient temperature and isn’t classified as a particularly hazardous material, at least not in the moderate research volumes most folks use.
A couple of studies caution that direct contact or inhalation isn’t wise, but in reality, gloves, goggles, and standard ventilation usually do the trick. This user-friendliness brings more peace of mind, especially for those supervising newcomers in teaching labs. Some teachers mention they feel more confident letting grad students handle it compared to the more volatile halogenated aromatics or heavier metals complexes, which can demand stricter containment and PPE protocols.
The greater story comes from what you can actually do with the product. In pharmaceutical research, the two hydroxyl groups become critical contact points during the formation of fused heterocyclic rings, such as in triazolopyridazines or pyridazinones. Peptide chemists hoping to introduce water solubility and structural rigidity into their sequences have sometimes explored this dihydroxy motif, since it allows for further esterification, phosphorylation, or even oxidation without breaking the aromatic core.
One senior synthesis chemist I know developed a whole series of antitumor lead candidates using 3,6-Dihydroxypyridazine to provide an anchor for biaryl coupling. By comparison, using a mono-hydroxy variant forced more rounds of protection and deprotection, often resulting in lower yields and more solvent waste. This streamlined workflow lets teams spend more time on iterative optimization, not paperwork and rework. Journals highlight its utility in synthesizing nitrogen-rich frameworks, which can help mimic natural products or fine-tune drug-like properties—elements that continue to occupy the center stage of early drug discovery.
Outside of therapeutics, polymer chemists talk about how dihydroxylated scaffolds open up new avenues for developing hydrogels, specialty coatings, and stimuli-responsive materials. I spoke to a postdoc last year working on a conductive polymer project. She found that introducing 3,6-Dihydroxypyridazine led to more consistent cross-linking densities, yielding films with higher thermal stability and mechanical strength. Her team measured up to 30 percent better conductivity compared to more traditional monomers lacking the dual-hydroxy group, which they credited directly to the improved hydrogen network afforded by this structure.
One overlooked area in evaluating such molecules is the synthesis route itself. Chemists and purchasers alike look for compounds that don’t overburden the purification process. 3,6-Dihydroxypyridazine tends to crystallize cleanly after synthesis, sparing lengthy chromatography or exotic extraction steps. It allows for both small-scale and kilo-scale syntheses, making it a practical choice for both academic projects and exploratory industrial runs. The high purity ratings commonly available—usually at or over 98 percent—further support its candidacy as a research staple, slashing the risk of side product interference or analytical headaches later on.
Contrast this with some substituted pyridines or triazines, where purity falls short, forcing interventions that eat away at your research budget and time. Many suppliers offering this compound make clear that their product comes with a certificate of analysis, assuring transparency and traceability—allowing researchers to compare batch histories and performance across experiments. In a field where reproducibility matters more each year, those details aren't minor footnotes; they're vital tools for credible science.
No discussion of a reliable research chemical would be right without considering cost and supply stability. A compound can be as fascinating as it likes, but if it ships rarely or breaks the bank, most scientists will look elsewhere eventually. 3,6-Dihydroxypyridazine remains accessible from multiple recognized chemical suppliers, with pricing that matches its behavior as a specialty, rather than a commodity, chemical. It isn’t usually what you’d reach for if you only need a basic aromatic ring, given its price, but for work mandating precise functionality and stability, most labs believe the return justifies the spend.
As global commerce faces new challenges, from supply chain delays to quality assurance concerns, products with multiple reputable sources often win out. Labs stick with what they trust, favoring products that deliver consistent results and aren't tied to a single point of origin. Over the past five years, I’ve heard remarkably few cases of backorder or unexpected shortages in this segment—a sign that both manufacturers and distributors understand the ongoing, if niche, demand.
Today, sustainability is more than a buzzword in chemistry. That’s pushing many product developers and researchers to reconsider the lifecycle and origin of their starting materials. 3,6-Dihydroxypyridazine’s synthesis pathway can sometimes use greener solvents and avoids the high-energy input required by some of its halogenated or metal-complexing cousins. There’s room for greener synthesis, especially as more teams swap traditional nitro reductions or harsh oxidation steps for catalytic or bio-inspired alternatives. Journals covering green chemistry often include hydroxylated pyridazines in their reviews for being amenable to less waste-intensive methods.
Emerging work in biocatalysis and continuous manufacturing could make this compound even more relevant moving forward. I spoke with a research team using immobilized enzymes to streamline the hydroxy-introduction step, cutting down both solvent use and hazardous byproducts. Not only does this method save costs and effort, it leads to less stress when working with environmental compliance teams. As more grant bodies pressure researchers to consider environmental impact, 3,6-Dihydroxypyridazine, especially when sourced from sustainably audited suppliers, could win even greater favor in grant proposals and peer-reviewed publication.
Trust doesn’t just come from a data sheet—it’s forged in day-to-day lab work. Faculty advisors and senior researchers often draw from years of lived experience with various research chemicals. In conversations, one theme stands out: reliability. There’s relief in knowing a product won’t introduce weird, unexplained artifacts or fail to meet established purity benchmarks. Some of the largest pharmaceutical firms, while always on the hunt for new scaffolds, still fall back on time-tested intermediates like 3,6-Dihydroxypyridazine for exploratory chemistry, simply because the compound’s profile supports both creativity and confidence in results.
Over the past decade, I’ve seen a gradual uptick in forum posts and conference presentations where chemists recommend it for niche projects. These endorsements often mention its consistent performance during scale-up and minimal batch-to-batch variability. Such feedback seldom gets published formally, but within the community, word-of-mouth carries plenty of weight. For students and young scientists coming up in the field, learning which products veterans trust provides a valuable shortcut past years of trial and error.
No chemical product is flawless, and genuine commentary must acknowledge ongoing challenges. Price can be a sticking point for startups or smaller universities, especially those in regions where international shipping adds to costs. While the well-established supply lines mostly keep prices steady, trademarked or ultra-high purity variants still command premiums, squeezing limited research budgets. Institutions hoping to switch to more sustainable suppliers or in-house synthesis often have to juggle cost, practicality, and regulatory documentation—rarely an easy balance.
On the technical front, researchers working at extreme pH or with oxidizing agents sometimes note that the hydroxy groups on 3,6-Dihydroxypyridazine can be more reactive than expected. This isn’t always bad—a clever chemist can exploit that reactivity—but it means more controls in certain experimental setups. Product developers who can offer modified or protected forms at affordable prices may draw in more customers needing stability under harsher reaction conditions.
Another challenge turns on the documentation. While most suppliers now include a decent level of traceability and analytical transparency, a few laggards in the industry still ship with light technical data, especially in some global markets. This can mean extra work double-checking purity or structure via NMR or HPLC before diving into complex synthesis. Open science initiatives and standards pushed by funding agencies may eventually raise the industry bar, but for now, more thorough technical reports and third-party validation would serve the research community even better.
Most practical solutions center on collaboration. Research consortiums have started negotiating volume discounts and shared purchase agreements among neighboring institutions, lowering costs and ensuring steady supply. Amateur chemists and independent researchers often trade experience on specialty forums, sharing tips on handling, purification, and even in-house synthesis strategies that cut costs without sacrificing quality. Transparency and dialogue with suppliers have also improved—many now issue faster technical support and clearer batch histories in response to feedback from both industry and academia.
Some laboratories are moving toward greener and shorter synthesis routes, borrowing ideas from flow chemistry and bio-inspired catalysis, which could further help by dropping costs and reducing waste. Smarter packaging and updated shelf-life studies can cut unnecessary losses and reduce the pressure to rush through inventory. In discussions with suppliers, most agree that as customer bases become savvier, the push for better value, stronger documentation, and more sustainable options will only keep rising.
Over years of laboratory work, conferences, and late-night troubleshooting sessions, I’ve learned that the right chemical intermediate can make or break a research project. 3,6-Dihydroxypyridazine has earned its reputation as a unique and adaptable piece of the chemist’s toolkit. Rather than offering only a slight tweak on existing pyridazine products, it opens doors precisely because it blends reactivity, user-friendliness, and reproducible performance. Researchers focused on drug design, chemical synthesis, polymer development, and even eco-conscious chemistry see it as more than just another catalog offering—it’s a time-tested option that intersects with the evolving needs of modern science. For those builders and thinkers at the lab bench, that’s where the true value begins.